
Fortune
September 17, 2021
“Immix Biopharma, a Los Angeles-based oncology drug company, filed for an initial public offering …”
Fortune
September 17, 2021
“Immix Biopharma, a Los Angeles-based oncology drug company, filed for an initial public offering …”
Categories:
Tags: